Ono Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	92,654	59,328	163,734	143,532	105,025
Depreciation & Amortization	37,752	26,894	18,140	17,451	17,721
Loss (Gain) From Sale of Assets	2,200	7,981	14,885	1,498	3,404
Other Operating Activities	-17,305	-45,211	-57,338	-6,655	-34,284
Change in Accounts Receivable	1,579	7,391	-19,782	-14,513	-15,283
Change in Inventory	18,962	12,435	-3,420	-2,945	-2,464
Change in Accounts Payable	-21,462	18,786	-5,734	18,654	8,177
Change in Other Net Operating Assets	22,441	-5,145	175	2,588	-20,467
Operating Cash Flow	136,821	82,459	110,660	159,610	61,829
Operating Cash Flow Growth	65.93%	-25.48%	-30.67%	158.15%	-16.42%
Capital Expenditures	-6,024	-5,431	-4,020	-5,340	-5,497
Sale of Property, Plant & Equipment	21	9	903	6	14
Cash Acquisitions	-	-364,816	-	-	-
Sale (Purchase) of Intangibles	-47,246	-2,559	-16,809	-9,157	-6,780
Investment in Securities	14,233	236,764	69,290	-84,731	19,969
Other Investing Activities	-844	-752	-1,287	-1,037	-1,668
Investing Cash Flow	-39,860	-136,785	48,077	-100,259	6,038
Short-Term Debt Issued	5,389	-	-	-	-
Long-Term Debt Issued	-	150,000	-	-	-
Total Debt Issued	5,389	150,000	-	-	-
Long-Term Debt Repaid	-30,000	-15,000	-	-	-
Total Debt Repaid	-30,000	-15,000	-	-	-
Net Debt Issued (Repaid)	-24,611	135,000	-	-	-
Repurchase of Common Stock	-1	-1	-50,010	-1	-30,007
Common Dividends Paid	-37,532	-37,516	-37,183	-29,742	-27,666
Other Financing Activities	-3,349	-3,184	-2,655	-2,741	-2,564
Financing Cash Flow	-65,493	94,299	-89,848	-32,484	-60,237
Foreign Exchange Rate Adjustments	1,012	-1,548	1,116	155	436
Miscellaneous Cash Flow Adjustments	-	1	-	1	1
Net Cash Flow	32,480	38,426	70,005	27,023	8,067
Free Cash Flow	130,797	77,028	106,640	154,270	56,332
Free Cash Flow Growth	69.80%	-27.77%	-30.87%	173.86%	-15.87%
Free Cash Flow Margin	25.36%	15.82%	21.21%	34.50%	15.59%
Free Cash Flow Per Share	278.23	163.97	222.15	315.90	113.45
Cash Interest Paid	2,158	1,408	92	74	70
Cash Income Tax Paid	16,413	44,060	56,431	6,637	34,293
Levered Free Cash Flow	64,834	71,819	79,783	116,639	18,091
Unlevered Free Cash Flow	67,046	72,725	79,861	116,694	18,143
Change in Working Capital	21,520	33,467	-28,761	3,784	-30,037

Source: S&P Global Market Intelligence. Standard template. Financial Sources.